[Specificities of chemotherapy in elderly cancer patients].
The management of cancer in the elderly patients is becoming a major problem of public health. The population is becoming older, the risk of cancer is increasing with age and therapeutic tools are improving. The numerous pharmacological changes of age might influence the pharmacokinetic and pharmacodynamic variables of many drugs, in particular the agents of chemotherapy. The development of news drugs, with less toxicity, administrated weekly or orally, and of supportive care (hematological growth factors, nutritional support) allows proposing specific treatment to elderly patients with cancer. However, evidence-based medicine data are lacking to define optimal schedules in this population due to low inclusion rates in clinical trials. This paper explores the specificities of chemotherapy in elderly patients with cancer.
Delbaldo
C
C
Service d'Oncologie Médicale, Unité d'Onco-gériatrie, CHU Henri Mondor, Université Paris 12, Paris, France.
Delbado
C
C
Caillet
P
P
Pouessel
D
D
Paillaud
E
E
Culine
S
S
D000368:Aged; D000375:Aging / Q000502:physiology; D015577:Geriatric Assessment; D006801:Humans; D014571:Urologic Neoplasms / Q000188:drug therapy*